Blood Test Can Quickly Diagnose Sarcoidosis
Researchers have developed a tool to rapidly and inexpensively diagnose sarcoidosis using a simple blood test.
Researchers have developed a tool to rapidly and inexpensively diagnose sarcoidosis using a simple blood test.
Researchers have developed a tool to rapidly and inexpensively diagnose sarcoidosis using a simple blood test.
Read MoreResearch reinforced the efficacy and safety of Acthar Gel, an FDA-approved therapy for autoimmune and inflammatory diseases like sarcoidosis.
Read MoreThe phase 2 clinical trial is expected to be a multi-center, randomized, double-blind, placebo-controlled study assessing the drug’s safety and effectiveness in treating approximately 90 pulmonary sarcoidosis patients.
Read MoreThe new guide can assist providers in learning and practicing skills to prevent or manage respiratory symptoms in patients with chronic lung disease.
Read MoreThe expansion of the clinical trial follows the clearance of an Investigational New Drug application by the US Food and Drug Administration, announced earlier this year.
Read MoreA majority of African American patients with symptomatic sarcoidosis treated with Acthar Gel saw clinical improvement in a number of health factors, including lung function and quality of life, according to data presented at ATS 2022.
Read MoreThe Foundation for Sarcoidosis Research has announced the formation of a new patient speakers’ bureau.
Read MoreGene profiles of bronchoalveolar lavage cells are linked with phenotypic manifestations of sarcoidosis, according to results published in the European Respiratory Journal.
Read MoreThe Foundation for Sarcoidosis Research, a nonprofit organization dedicated to finding a cure and improving care for sarcoidosis patients, recently published a survey of vaccination rates in this patient population.
Read MoreNorthwestern University’s Deborah Winter, PhD, has been awarded a $50,000 ATS/Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis.
Read MoreaTyr Pharma Inc has completed the target enrollment in its Phase 1b/2a clinical trial for ATYR1923 in patients with pulmonary sarcoidosis.
Read MoreThe ATS has issued the first official clinical practice guideline for sarcoidosis, which includes recommendations for diagnosis and detection.
Read MoreA study found an association between Acthar Gel treatment and improved overall health status in 95% of patients with advanced symptomatic sarcoidosis.
Read MoreAustrian researchers have discovered mutations in genes that regulate the metabolic sensor mTOR in patients with familial sarcoidosis, according to a study published in the European Respiratory Journal.
Read MoreDeborah Winter, PhD, of Northwestern University has been awarded the new ATS Foundation/Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis.
Read MoreResearchers report that male gender and tobacco exposure (regardless of pack years) are independent risk factors for development of ocular sarcoidosis (OS).
Read MoreSystemic and clinical pulmonary-only sarcoidosis may be caused by different environmental exposures that ultimately lead to these different subsets of the same disease.
Read More